Biomarkers at Bedside: i-STATs Point-of-Care Test Biomarkers at Bedside:
Biomarkers at Bedside: i-STAT’s Point-of-Care Test Produces Cardiac Biomarker Troponin Results Withs
Read MorePosted by Clinical Lab Products | Mar 4, 2004 | Cerebrovascular, Miscellaneous |
Biomarkers at Bedside: i-STAT’s Point-of-Care Test Produces Cardiac Biomarker Troponin Results Withs
Read MorePosted by Clinical Lab Products | Jan 9, 2004 | Miscellaneous |
Introduces Enhanced Version of Medisense Precision PCX System
Read MorePosted by Clinical Lab Products | Dec 11, 2003 | Miscellaneous, Osteoporosis |
AusAm Biotechnologies Receives Approval to Market Test for Kidney Disease AusAm Biotechnologies Inc has received the CE Mark of approval for the Microalbumin Plus™, which aids in the detection of microalbuminari
Read MorePosted by Clinical Lab Products | Dec 6, 2003 | Cancer, Miscellaneous, Osteoporosis |
ImmuKnow™: A Pharmacodynamic Assay for Managing Immunosuppressive Drug Therapy
Read MorePosted by Clinical Lab Products | Dec 4, 2003 | Miscellaneous |
By Nicholas Borgert Bio-Rad Laboratories has expanded its TOX/See Rapid Urine Drug Screen platform with new capabilities to detect tricyclic antidepressants (TCA) and Ecstasy (MDMA). The new tests have been added to a TOX/See test menu tha
Read More